Kimel Family Centre for Brain Health and Wellness

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50+
SponsorBaycrest

About this trial

Participants (n=450; aged 50+; without a diagnosis of dementia; sufficiently fluent in English to complete the assessments and engage in programming) receive a comprehensive dementia risk assessment, including nonmodifiable and modifiable risk factors, from which they receive a Personalized Dementia Risk Report and Program Strategy, indicating their health conditions increasing and their risk level in five modifiable risk domains: physical activity, brain- healthy eating, cognitive engagement, social connections, and mental wellbeing. Equipped with this information, participants enroll in programs within the Centre to address their risk factors. Changes to their dementia risk, cognition, and Personalized Program Strategy are communicated through re-assessments of risk factors every six months (risk and cognition) and every year (comprehensive assessment).

Eligibility criteria

Qualifiers

Aged 50 years or older

Sufficiently fluent in English to complete the assessments and participate in programming.

Disqualifiers

Diagnosis of dementia.

Trial design

Treatments tested in this trial

  • Physical Activity
  • Brain-healthy Eating
  • Cognitive Engagement
  • Social Connections
  • Mental Wellbeing

Treatment groups

450 Participants
are divided into 5 treatment groups

Sponsors and collaborators